Xiaodong Chen MS, PhD

Xiaodong Chen is working as a senior research investigator at BMS. He is a drug product development team leader who is responsible for developing, recommending and implementing development strategies of biologics drug product formulation, device and primary packaging, tech transfer to commercial manufacturing, registrational filing. Xiaodong is also leading the efforts of developing computational models to optimize lyophilization cycles of commercial products (NULOJIX®, EMPLICITI™) as well as developing lyo cycles for late stage biological and small molecule parenteral drug products. Xiaodong has co-authored two book chapters and a number of publications in this field. In addition, he is on the editorial advisory board of Journal of Pharmaceutical Sciences and invited reviewer for NIH contract proposals. He has advised two NSF funded projects and served as session chairs in AiChe and AAPS Annual Conferences. Xiaodong received his Ph.D. from the Ohio State University.